170 related articles for article (PubMed ID: 10522271)
21. Biotransformation of medetomidine in the rat.
Salonen JS; Eloranta M
Xenobiotica; 1990 May; 20(5):471-80. PubMed ID: 2349806
[TBL] [Abstract][Full Text] [Related]
22. Metabolism and excretion of RWJ-333369 [1,2-ethanediol, 1-(2-chlorophenyl)-, 2-carbamate, (S)-] in mice, rats, rabbits, and dogs.
Mamidi RN; Mannens G; Annaert P; Hendrickx J; Goris I; Bockx M; Janssen CG; Kao M; Kelley MF; Meuldermans W
Drug Metab Dispos; 2007 Apr; 35(4):566-75. PubMed ID: 17220243
[TBL] [Abstract][Full Text] [Related]
23. Biotransformation of the organic nitrate trans-N-(4-nitroxycyclohexyl)acetamide in dogs.
Zell C; Neidlein R; Strein K
Arzneimittelforschung; 1994 Sep; 44(9):1021-8. PubMed ID: 7986238
[TBL] [Abstract][Full Text] [Related]
24. Application of hyphenated LC/NMR and LC/MS techniques in rapid identification of in vitro and in vivo metabolites of iloperidone.
Mutlib AE; Strupczewski JT; Chesson SM
Drug Metab Dispos; 1995 Sep; 23(9):951-64. PubMed ID: 8565786
[TBL] [Abstract][Full Text] [Related]
25. Identification of major biliary and urinary metabolites of ecabapide in rats.
Nakaoka M; Tsumura M; Ichikawa E; Suzuki W; Hakusui H; Nakazawa T
Xenobiotica; 1996 Sep; 26(9):983-94. PubMed ID: 8893045
[TBL] [Abstract][Full Text] [Related]
26. Liquid chromatography-mass spectrometry and liquid chromatography-NMR characterization of in vitro metabolites of a potent and irreversible peptidomimetic inhibitor of rhinovirus 3C protease.
Zhang KE; Hee B; Lee CA; Liang B; Potts BC
Drug Metab Dispos; 2001 May; 29(5):729-34. PubMed ID: 11302940
[TBL] [Abstract][Full Text] [Related]
27. Effect of KCA-098, a new benzofuroquinoline derivative, on bone mineral metabolism.
Kojima M; Tsutsumi N; Nagata H; Itoh F; Ujiie A; Kawashima K; Endo H; Okazaki M
Biol Pharm Bull; 1994 Apr; 17(4):504-8. PubMed ID: 8069257
[TBL] [Abstract][Full Text] [Related]
28. Metabolism of the enantiomers of 2-hydroxy-N-cyclopropylmethylmorphinan in dog and man.
Vane FM; Ellis DH; Rao J; Petrin M; Blount JF; Mohacsi E; Szuna A; Kamm JJ
Biomed Mass Spectrom; 1978 Aug; 5(8):498-507. PubMed ID: 687784
[TBL] [Abstract][Full Text] [Related]
29. Metabolism, pharmacokinetics, and excretion of the substance P receptor antagonist CP-122,721 in humans: structural characterization of the novel major circulating metabolite 5-trifluoromethoxy salicylic acid by high-performance liquid chromatography-tandem mass spectrometry and NMR spectroscopy.
Colizza K; Awad M; Kamel A
Drug Metab Dispos; 2007 Jun; 35(6):884-97. PubMed ID: 17360832
[TBL] [Abstract][Full Text] [Related]
30. Biotransformation of nifedipine in rat and dog.
Scherling D; Karl W; Radtke M; Ahr HJ; Siefert HM
Arzneimittelforschung; 1992 Nov; 42(11):1292-300. PubMed ID: 1492841
[TBL] [Abstract][Full Text] [Related]
31. Disposition of cyclosporine in several animal species and man. I. Structural elucidation of its metabolites.
Maurer G; Loosli HR; Schreier E; Keller B
Drug Metab Dispos; 1984; 12(1):120-6. PubMed ID: 6141902
[TBL] [Abstract][Full Text] [Related]
32. Biotransformation of nevirapine, a non-nucleoside HIV-1 reverse transcriptase inhibitor, in mice, rats, rabbits, dogs, monkeys, and chimpanzees.
Riska PS; Joseph DP; Dinallo RM; Davidson WC; Keirns JJ; Hattox SE
Drug Metab Dispos; 1999 Dec; 27(12):1434-47. PubMed ID: 10570025
[TBL] [Abstract][Full Text] [Related]
33. Identification of the metabolites of roxithromycin in humans.
Zhong D; Li X; Wang A; Xu Y; Wu S
Drug Metab Dispos; 2000 May; 28(5):552-9. PubMed ID: 10772634
[TBL] [Abstract][Full Text] [Related]
34. Metabolism of the antipsychotic drug tiospirone in humans.
Mayol RF; Jajoo HK; Klunk LJ; Blair IA
Drug Metab Dispos; 1991; 19(2):394-9. PubMed ID: 1676643
[TBL] [Abstract][Full Text] [Related]
35. Major routes of naftifine biotransformation in laboratory animals and man.
Schatz F; Haberl H; Battig F; Jobstmann D; Schulz G; Nefzger M; Czok R; Nikiforov A
Arzneimittelforschung; 1986 Feb; 36(2):248-55. PubMed ID: 3964331
[TBL] [Abstract][Full Text] [Related]
36. Disposition and metabolism of radiolabeled casopitant in humans.
Pellegatti M; Bordini E; Fizzotti P; Roberts A; Johnson BM
Drug Metab Dispos; 2009 Aug; 37(8):1635-45. PubMed ID: 19420128
[TBL] [Abstract][Full Text] [Related]
37. Excretion and metabolism of the antihypertensive agent, RWJ-26240 (McN-5691) in dogs.
Wu WN; Masucci JA; Caldwell GW; Carson JR
Drug Metab Dispos; 1998 Feb; 26(2):115-25. PubMed ID: 9456297
[TBL] [Abstract][Full Text] [Related]
38. Metabolism of a new P-glycoprotein inhibitor HM-30181 in rats using liquid chromatography/electrospray mass spectrometry.
Paek IB; Ji HY; Kim MS; Lee G; Lee HS
Rapid Commun Mass Spectrom; 2006; 20(9):1457-62. PubMed ID: 16586459
[TBL] [Abstract][Full Text] [Related]
39. In vitro effect of KCA-098, a derivative of coumestrol, on bone resorption of fetal rat femurs.
Tsutsumi N; Kawashima K; Arai N; Nagata H; Kojima M; Ujiie A; Endo H
Bone Miner; 1994 Mar; 24(3):201-9. PubMed ID: 8019207
[TBL] [Abstract][Full Text] [Related]
40. Characterization of metabolic profile of mosapride citrate in rat and identification of two new metabolites: Mosapride N-oxide and morpholine ring-opened mosapride by UPLC-ESI-MS/MS.
Sun X; Niu L; Li X; Lu X; Li F
J Pharm Biomed Anal; 2009 Aug; 50(1):27-34. PubMed ID: 19362796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
